• br Fig E ect of ITH on the tubulin

  2022-05-19

  

  Fig. 4. Effect of ITH-6 on the tubulin polymerization. The tu-bulin polymerization assay was performed as per manufacturer’s protocol. The change in optical density (OD) at 340 nm was plotted against time in min for ITH-6 at 100 μM (green) was compared with control (blue), paclitaxel at 10 μM (oran

• br Targeting ANGPTL impairs AFPGC tumor growth

  2022-05-19

  

  3.5. Targeting ANGPTL6 impairs AFPGC tumor growth in vivo To further assess the contribution of ANGPTL6 to AFPGC tumor-igenesis, we performed in vivo studies using a lentivirus shRNA ap-proach. As expected, the mean tumoral volume or weight of the shANGPTL6 group was significantly smaller than

• br Although more sensitive than HMB Melan A is considered

  2022-05-17

  

  Although more sensitive than HMB-45, Melan A is considered not sufficiently specific [22] and not quite as sensitive as S100 protein because it is not positive in all melanomas. It can also stain macrophages/melanoph-ages, whereas S100 protein and HMB45 do not as a rule. Currently, SOX-10 is un

• br Figure See previous page Organoid responses to combined

  2022-05-17

  

  Figure 5. (See previous page). Organoid responses to combined treatment with epirubicin, oxaliplatin, and 5-FU. Quantification of flow cytometric cell viability analysis at 0, 24, 48, 72, and 96 hours after treatment with combined epirubicin, oxaliplatin, and 5-FU of (A) huTGOs and (B) huFGOs. Rep

• br analysis and interpretation EMdL EB ME Statistical analysis

  2022-05-17

  

  analysis and interpretation: EMdL, EB, ME- Statistical analysis: EMdL, EB, − Manuscript preparation: EMdL, EB, LGMvdG, KME, CJHvdV, LB, BAB, ME- Manuscript editing: EMdL, EB, LGMvdG, KME, CJHvdV, LB, BAB, ME- Manuscript review: EMdL, EB, LGMvdG, KME, CJHvdV, LB, BAB, ME. No conflict of in

• br Table br Antibody information br

  2022-05-10

  

  Table 2 Antibody information. Name Company Catalog number Antibody concentration lower side of the filter were counted in 5 randomly selected fields per sample using a light microscope (magnification, 200×; Nikon Corporation). Detailed protocol was described in our previous study (Sun

• br Results br Demographic data br Between and patients diagnosed

  2022-05-10

  

  3. Results 3.1. Demographic data Between 1990 and 2012, 144 patients diagnosed with endometrial carcinoma FIGO stage IIIA, B or C1 were identified. Twenty-one patients received adjuvant chemotherapy alone and 19 patients received no ad-juvant treatment. Those two groups were excluded from th

• br Department of Thoracic Surgery Department of Medical

  2022-05-09

  

  1Department of Thoracic Surgery 2Department of Medical Oncology and Hematology 3Institute of Surgical Pathology 4Institute of Neuropathology, University Hospital Zurich, Zurich, Switzerland Address for correspondence: Alessandra Curioni-Fontecedro, MD, PhD, Department of Medical Oncology

• Cellular Signalling br Contents lists available

  2022-05-09

  

  Cellular Signalling 62 (2019) 109350 Contents lists available at ScienceDirect Cellular Signalling journal homepage: www.elsevier.com/locate/cellsig Adipose derived stem U0126-EtOH promote tumor metastasis in breast Cancer cells T by stem cell factor inhibition of miR20b Haiqian Xu

• br In this work potential geometric

  2022-05-06

  

  In this work, potential geometric mismatches between US and CBCT were not explicitly accounted for. Factors such as probe pressure, gas movement, bulk, and patient motion could cause positional discrepancies between the apparent position of the uterus on the two modalities. However, preliminary me

• Loxapine Succinate br Results br Scheme for Unbiased Prediction of Tumor

  2022-05-04

  

  Results Scheme for Unbiased Prediction of Tumor Location by Gene Expression To identify genomic features characteristic of anatomic left-side or right-side tumors, we define predictors of anatomic location based on gene expression. Statistical classification methods were used to predict anat

• br Fig Temporal evolution of measurements longitudinal cohort n

  2022-05-04

  

  Fig. 2. Temporal evolution of measurements longitudinal cohort (n = 25) and comparison with the original cohort (n = 115). Native T1 values display in early months after receiving cancer-related therapies, dropping to lower values approximately 3 months post-therapy in both longitudinal and origin

• br Qing Wei et al br Table

  2022-04-29

  

  Qing Wei et al Table 6 Tumor Response Assessment at First Imaging Evaluation ctDNA Amount ctDNA HER2 CNV RAS/BRAF First Radiologic First Treatment First Treatment No. IHC Regimen Evaluation Baseline Evaluation Baseline Evaluation Abbreviations: Chemo ¼ chemotherapy

• br Ohtsu A Shah MA Van Cutsem E et al

  2022-04-29

  

  35. Ohtsu A, Shah MA, Van Cutsem E, et al. Bevacizumab in combination with chemotherapy as first-line ther-apy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol. 2011;29:3968–3976. 36. Kim NK, Park YS, Heo DS. A phase III randomized study o

• br En el presente art

  2022-04-28

  

  En el presente artículo se revisan las pacientes trata-das mediante técnicas quirúrgicas oncoplásticas y que han recibido RIO. Material y método Se realiza un estudio prospectivo desde mayo de 2015 hasta agosto de 2018 analizando los datos de las 148 pacientes intervenidas por cáncer de mama

144 records 2/10 page Previous Next 12345 Next 5 pages Last page